TITLE

Adrenocortical suppression increases the risk of relapse in nephrotic syndrome

AUTHOR(S)
Abeyagunawardena, Asiri S.; Hindmarsh, Peter; Trompeter, Rkhard S.
PUB. DATE
July 2007
SOURCE
Archives of Disease in Childhood;Jul2007, Vol. 92 Issue 7, p585
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: Children with nephrotic syndrome (NS) are usually treated with long-term low dose alternate day prednisolone with or without glucocorticoid sparing therapy, such as levamisole or ciclosporin, to maintain remission. The degree of hypothalamic-pituitary-adrenal axis (HPA) suppression with such therapeutic strategies has not been studied systematically. HPA suppression could cause a relapse or adrenal crisis. Study design: To study the risks of HPA suppression, a modified low dose synacthen test (0.5 μg) was administered to 32 patients (22 male,10 female) with a mean age of 9.7 years (range 3.8-17.6 years) with NS receiving long-term alternate day prednisolone for over 12 months. Twelve patients received alternate day prednisolone, 11 alternate prednisolone+levamisole and nine alternate prednisolone+ciclosporin. All patients were followed up for 3 years and the relapse rate noted. Results: 20/32 (62.5%) patients had a peak serum cortisol concentration of <500 nmol/1, which suggested suboptimal cortisol secretion and possible HPA suppression. 10/12 children in the prednisolone group and 8/11 in the levamisole group had a suboptimal cortisol response compared with 2/9 in the ciclosporin group. During follow-up, the 20 children who had a suboptimal cortisol response had significantly more relapses (95 relapses) compared to the 12 children with a normal cortisol response who had 24 relapses (p=0.01). Conclusions: Children with NS receiving long-term alternate day prednisolone therapy are at risk of developing HPA suppression and should be evaluated using the modified synacthen test. Children with evidence of HPA suppression are at a greater risk of relapse.
ACCESSION #
25765841

 

Related Articles

  • HPA axis recovered within 6 to 12 weeks of infant prednisolone therapy.  // Endocrine Today;Nov2013, Vol. 11 Issue 11, p20 

    The article discusses a research study published in a 2013 issue of the "Journal of Clinical Endocrinology and Metabolism" which showed infants' recovery of their hypothalamic-pituitary-adrenalaxis (HPA) within six to 12 weeks of glucocorticoid treatment, and circadian variation in salivary...

  • The 'koala stress syndrome' and adrenal responsiveness in the critically ill. Marik, Paul E.; Levitov, Alexander // Intensive Care Medicine;Nov2010, Vol. 36 Issue 11, p1805 

    The authors reflect on the koala stress syndrome in patients with critical illness-related corticosteroid insufficiency (CIRCI). It says that the release of cortisol results from the activation of the hypothalamic-pituitary-adrenal (HPA) axis due to various stressors including infections, trauma...

  • Megace Mystery: A Case of Central Adrenal Insufficiency. Mehta, Kunal; Weiss, Irene; Goldberg, Michael D. // Case Reports in Endocrinology;12/6/2015, p1 

    Megestrol acetate (MA) is a synthetic progestin with both antineoplastic and orexigenic properties. In addition to its effects on the progesterone receptor, MA also binds the glucocorticoid receptor. Some patients receiving MA therapy have been reported to develop clinical features of...

  • Apparent Hypothalamic-Pituitary-Adrenal Axis Suppression via Reduction of Interleukin-6 by Glucocorticoid Therapy in Systemic Autoimmune Diseases. Fujio, Natsuki; Masuoka, Shotaro; Shikano, Kotaro; Kusunoki, Natsuko; Nanki, Toshihiro; Kawai, Shinichi // PLoS ONE;12/8/2016, Vol. 11 Issue 12, p1 

    Context: Suppression of the hypothalamic-pituitary-adrenal (HPA) axis is a serious complication of systemic glucocorticoid therapy. Objective: To clarify the influence of proinflammatory cytokines on the HPA axis after onset of glucocorticoid therapy in patients with systemic autoimmune...

  • The Cortisol Response to Anticipated Intergroup Interactions Predicts Self-Reported Prejudice. Bijleveld, Erik; Scheepers, Daan; Ellemers, Naomi // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Objectives: While prejudice has often been shown to be rooted in experiences of threat, the biological underpinnings of this threat-prejudice association have received less research attention. The present experiment aims to test whether activations of the hypothalamus-pituitary-adrenal (HPA)...

  • The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Lightman, Stafford L.; Conway-Campbell, Becky L. // Nature Reviews Neuroscience;Oct2010, Vol. 11 Issue 10, p710 

    The classical concept of hypothalamus-pituitary-adrenal (HPA) homeostasis comprises a feedback system within which circulating levels of glucocorticoid hormones maintain the brain and body in an optimal steady state. However, studies involving new techniques for investigating the real-time...

  • Role of biochemical assessment in management of corticosteroid withdrawal. Walsh, John P.; Dayan, Colin M. // Annals of Clinical Biochemistry;May2000, Vol. 37 Issue 3, p279 

    The article examines the role of biochemical tests of adrenal function in the management and monitoring of glucocorticoid withdrawal. The physiology of the hypothalamo-pituitary-adrenal (HPA) axis and the known effects of glucocorticoid treatment on the axis is reviewed. Dynamic tests of HPA...

  • Head Over Hepatocytes for FGF21. Potthoff, Matthew J.; Finck, Brian N. // Diabetes;Dec2014, Vol. 63 Issue 12, p4013 

    The article discusses a study by Q. Liang et al providing evidence that FGF21 brings out its hepatic gluconeogenic effects through actions in the hypothalamus and activation of the hypothalamic-pituitary-adrenal (HPA) axis. Topics discussed include a recent report showing that the effects of...

  • The Cortisol Response to Anticipated Intergroup Interactions Predicts Self-Reported Prejudice. Bijleveld, Erik; Scheepers, Daan; Ellemers, Naomi // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Objectives: While prejudice has often been shown to be rooted in experiences of threat, the biological underpinnings of this threat-prejudice association have received less research attention. The present experiment aims to test whether activations of the hypothalamus-pituitary-adrenal (HPA)...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics